Mobil 1 50 th Anniversary: Ready for What’s Next
1.2.2024 15:30:00 CET | Business Wire | Press Release
ExxonMobil is proud to celebrate the 50th anniversary of the introduction of Mobil 1™ motor oil to the global marketplace. In 2024, ExxonMobil will commemorate its 50-year history of the Mobil 1™ brand with a series of initiatives across partnerships, motorsports, and virtual reality, each of which will highlight the brand’s legacy and what’s to come.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240201592966/en/
Beginning as the first full synthetic automotive motor oil and later expanding into a line of Mobil 1 branded oils, the Mobil 1 brand has been at the forefront of engine protection for gas-powered and more recently, hybrid and electric cars delivering unmatched quality and performance for the past five decades. Today, Mobil 1™ is the world’s leading synthetic motor oil brand with an unwavering commitment to innovation, collaboration and customers. With this iconic brand, ExxonMobil is excited to continue shaping the future of engine protection and performance.
One of the central components driving the celebration of Mobil 1 in this milestone year is a short film to encapsulate the brand’s journey. ExxonMobil has partnered with former Formula 1 racer and McLaren driver David Coulthard for the video to guide audiences in an immersive journey through the Mobil 1 brand’s evolution, influential collaborations and technological achievements.
Throughout the 2024 motorsports season, the Mobil 1 brand will celebrate its legacy with a series of specially designed liveries and other highlights of the Mobil 1 brand’s extensive racing history.
“ExxonMobil takes great pride in the Mobil 1 brand's legacy as a revolutionary synthetic motor oil,” said Laura Bustard, Mobil 1 Global Brand Manager. “From its inception 50 years ago, Mobil 1 motor oil has consistently set the standard for quality and performance and will continue to improve and excel for the next 50 years. Anyone with any knowledge of the automotive space or racing knows how iconic this brand has been and will be.”
The Mobil 1 brand’s journey through the last 50 years is a testament to ExxonMobil’s ability to push boundaries and their commitment to performance and sustainability. Mobil 1 has become the trusted choice of leading automakers, professional racers, and millions of drivers worldwide. The Mobil 1 brand's advanced oil formulations provide unparalleled protection against engine wear, extending engine life and reducing maintenance costs for consumers.
ExxonMobil recognizes that the Mobil 1 brand's success is not just a product of superior technology but a result of close collaboration with leading automakers, racing teams, and industry experts. These collaborations have allowed Mobil 1 to continually evolve and set new industry standards.
“The Mobil 1 brand remains dedicated to maintaining and growing meaningful relationships,” said Robert Shearer, Director of Global Sponsorships. “As we move forward into the future, we are excited to see a continuation of the collaborative innovation and intelligence that stems from our work with automakers, racing teams and other great partners. Track to road technology is seen with each improvement to Mobil 1 motor oil.”
About Mobil 1
The world's leading synthetic motor oil brand, Mobil 1 features anti wear technology that provides performance beyond our conventional motor oils. This technology allows Mobil 1 to meet or exceed the toughest standards of car builders and to provide exceptional protection against engine wear, under normal or even some of the most extreme conditions. Mobil 1 flows quickly in extreme temperatures to protect critical engine parts and is designed to maximize engine performance and help extend engine life. For more information, visit www.mobil1.com and follow @Mobil1 on Facebook, Instagram and Twitter.
About ExxonMobil
ExxonMobil, one of the largest publicly traded international energy and petrochemical companies, creates solutions that improve quality of life and meet society’s evolving needs.
The corporation’s primary businesses – Upstream, Product Solutions and Low Carbon Solutions – provide products that enable modern life, including energy, chemicals, lubricants, and lower emissions technologies. ExxonMobil holds an industry-leading portfolio of resources, and is one of the largest integrated fuels, lubricants, and chemical companies in the world. ExxonMobil also owns and operates the largest CO2 pipeline network in the United States. In 2021, ExxonMobil announced Scope 1 and 2 greenhouse gas emission-reduction plans for 2030 for operated assets, compared to 2016 levels. The plans are to achieve a 20-30% reduction in corporate-wide greenhouse gas intensity; a 40-50% reduction in greenhouse gas intensity of upstream operations; a 70-80% reduction in corporate-wide methane intensity; and a 60-70% reduction in corporate-wide flaring intensity.
With advancements in technology and the support of clear and consistent government policies, ExxonMobil aims to achieve net-zero Scope 1 and 2 greenhouse gas emissions from its operated assets by 2050. To learn more, visit exxonmobil.com and ExxonMobil’s Advancing Climate Solutions.
Follow us on LinkedIn, Instagram and X.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201592966/en/
Contact information
Sean Hixson
shixson@webershandwick.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom